Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study
Phase of Trial: Phase II
Latest Information Update: 28 Mar 2016
At a glance
- Drugs Etanercept (Primary)
- Indications Atherosclerosis; Cardiovascular disorders; Psoriasis
- Focus Therapeutic Use
- Acronyms MMAPPS
- 10 Jun 2017 Biomarkers information updated
- 22 Mar 2016 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 13 May 2015 Planned End Date changed from 1 Jan 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov record.